Buy Ajanta Pharma; target of Rs 2350: YES Securities

Buy Ajanta Pharma; target of Rs 2350: YES Securities

YES Securities is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2350 in its research report date May 10, 2022.      



Author: AliensFaith
HighTech FinTech researcher, university lecturer & Scholar. He is studying his second doctoral degree at the Hague International University. Studying different fields of Sciences gave him a broad understanding of various aspects of life. His recent researches covered AI, Machine-learning & Automation concepts. The Information Technology Skills & Knowledge gave his company a higher position over other regional high-tech consultancy services. The other qualities and activities which can describe him are a Hobbyist Programmer, Achiever, Strategic Thinker, Futuristic person, and Frequent Traveler.
%d bloggers like this: